文献速递传染病防控与疫情报告免疫规划

新型汉坦病毒分离株的致病性及基于新毒株的灭活疫苗的抗原性与免疫原性

Pathogenicity of novel hantavirus isolate and antigenicity and immunogenicity of novel strain-based inactivated vaccine.
PubMed 文献 · Vaccine · 2023-11-11

研究对从中国湖北疫区黑线姬鼠分离的新型HTNV HV004株进行致病性表征,并在BALB/c小鼠中评价其灭活疫苗的免疫原性。HV004株在乳鼠中致病性相似但高于标准株76-118和临床分离株HV114。铝佐剂灭活疫苗皮下接种后,小鼠产生剂量依赖性中和抗体和脾细胞刺激指数,IFN-γ+CD3+CD8+T细胞比例显著高于对照,并可完全抵抗HTNV攻击。

要点

  • HV004株在乳鼠中致病性相似但高于HTNV 76-118和HV114株。
  • 铝佐剂HV004灭活疫苗皮下接种可完全保护小鼠抵抗HTNV攻击。
  • 免疫小鼠产生剂量依赖性中和抗体和细胞免疫应答。

核心结论

  • 灭活HTNV疫苗可能刺激小鼠产生高水平中和抗体,并诱导体液和细胞免疫应答对抗中国中南地区流行株。

研究设计与样本

  • 在易感细胞和体内对HTNV 76-118标准株、HV114临床分离株和新型HV004分离株进行生物学和致病性表征。
  • 制备HV004株实验性灭活疫苗,在BALB/c小鼠中分析免疫原性。

主要发现

  • HV004株在乳鼠中致病性相似但高于HTNV 76-118和HV114株。
  • 铝佐剂灭活HTNV疫苗皮下接种后,腹腔攻击106 FFU/ml HTNV,提供完全保护。
  • 所有免疫组小鼠均产生血清中和抗体,随剂量增加而升高。
  • 免疫小鼠脾细胞刺激指数呈剂量依赖性。
  • 免疫小鼠脾脏中产IFN-γ的CD3+CD8+T细胞百分比显著高于对照小鼠。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hantaan virus (HTNV, Orthohantavirus hantanensae species, Hantaviridae family) is the main etiological agent responsible for hemorrhagic fever with renal syndrome (HFRS). The novel HTNV may pose a potential danger to the control and prevention of HFRS in China, which highlights the importance of vaccine development in public health management. In previous studies, our laboratory discovered and successfully isolated a new HTNV strain, HV004 strain, from Apodemus agrarius captured in an epidemic area in Hubei, China. METHODS: An initial biological and pathogenicity characterization of HTNV 76-118 (standard train), HV114 strain (a clinical isolate from Hubei province in 1986), and the novel isolate HV004 strain from the epidemic areas of Hubei province were performed in susceptible cells and in vivo. An experimental HV004 strain inactivated vaccine was prepared, and its corresponding immunogenicity was analyzed in BALB/c mice. RESULTS: HV004 strain had a similar but higher pathogenicity than HTNV 76-118 and HV114 in suckling mice. A subcutaneous vaccination (s.c.) with the inactivated HTNV vaccine adjuvanted with aluminum, followed by a challenge intraperitoneally with 106 FFU/ml HTNV, afforded full protection against an HTNV challenge. All immunized mice in every group elicited serum neutralizing antibodies with increasing dosages, which may protect mice from HTNV infection. A dose-dependent stimulation index of splenocytes was also observed in immunized mice. The percentage of IFN-γ-producing CD3+CD8+ T cells was significantly higher in the spleens of immunized mice than in those of control mice. CONCLUSIONS: These findings suggest that the inactivated HTNV vaccine may stimulate mice to produce high levels of antibodies with neutralization activity and elicit specific anti-HTNV humoral and cellular immune responses in BALB/c mice against the prevalent strain of HTNV in south central China.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Liu YY, Xu YQ, Zhong Y, et al. Pathogenicity of novel hantavirus isolate and antigenicity and immunogenicity of novel strain-based inactivated vaccine. Vaccine. 2023. PMID: 37953099. doi:10.1016/j.vaccine.2023.11.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。